Did You Know?

Editor’s Picks

Latest News

Aetna Expands Bundled Oncology Prior Authorizations, Easing Provider Burden and Accelerating Member Access to Care

Oncology bundling to support all eligible Medicaid members for all cancer typesFull roll-out across all Aetna businesses in 2027Originally published...

Medical Care Technologies Inc. (OTCID:MDCE) Reports Debt-Free Balance Sheet Alongside Continued StrainScan Pro Demos and Melanoma Scan Beta Review

Clean Balance-Sheet Milestone Reached While Melanoma Scan Beta, Wound Care Development, StrainScan Pro Demos and Subsidiary Operations Continue to Advance...

Amberstone Biosciences and Henlius Enter into Collaboration and License Agreement for Conditionally Activated T-Cell Engagers for Solid Tumors

IRVINE, Calif., Sept. 24, 2026 /PRNewswire/ -- Amberstone Biosciences, Inc., a preclinical-stage oncology company developing pH-gated, tumor-activated T-cell engagers (TCEs),...

TempraMed Expands Latin American Distribution Agreement with TEM and Receives Additional Commercial Order, Announces Private Placement

Amendment extends TEM relationship beyond Panama into additional Latin American markets, adds VIVI Med(TM) to the distribution framework, and supports...

Unbuzzd Wellness Appoints Michael “Zappy” Zapolin as CEO to Lead Innovative, Clinically Validated Alcohol Metabolism Accelerant

Vancouver, British Columbia--(Newsfile Corp. - September 23, 2026) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM...

error: Content is protected !!